3 Results for "

RPMI-8226 multiple myeloma cells

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "RPMI-8226 multiple myeloma cells" in MCE Product Catalog:

Cat. No.: HY-164099
CAS No.: 2982787-50-6
Research Areas:  

Cancer

LSD1/HDAC6-IN-2 (JBI-802) is an orally active LSD1/HDAC6/MAO-A inhibitor, with IC50 values of 5 nM, 11 nM, and 5 nM, respectively. LSD1/HDAC6-IN-2 can inhibit the growth of multiple myeloma cells MM.1S, MM.1R, and RPMI-8226. LSD1/HDAC6-IN-2 can be used for research on diseases such as acute myeloid leukemia and lymphoma .
loading...
    loading...
Cat. No.: HY-174984
CAS No.: 3098437-66-9
Target:  

p97 Caspase p62

Research Areas:  

Cancer

VCP/p97 IN-3 is a VCP/p97 allosteric inhibitor. VCP/p97 IN-3 shows the inhibitory activity against the VCP proteins with an IC50 of 9 nM and the mutant VCP proteins with IC50 of 12 nM (N660K) and 19 nM (V474A/D649A). VCP/p97 IN-3 increases K48-linked ubiquitination and the level of cleaved caspase-3. VCP/p97 IN-3 activates ER-stress and the UPR. VCP/p97 IN-3 inhibits tumor growth in RPMI-8226 cell subcutaneous xenograft mouse models. VCP/p97 IN-3 can be used for the study of multiple myeloma .
loading...
    loading...
Cat. No.: HY-149832
Target:  

Proteasome

Research Areas:  

Cancer

Anticancer agent 114 is a potent and orally active dipeptide boronic acid ester proteasome inhibitor with an IC50 value of 2.2 nM. Anticancer agent 114 has antiproliferative activity against the RPMI-8226 cells. Anticancer agent 114 can be used in research of multiple myeloma .
loading...
    loading...